Fundraising FoxUnshackled Ventures — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Reprogrambioreprogrambio.cominMar 2026
Reprogram Biosciences develops an in vivo immunotherapy that uses a therapeutic gene cocktail delivered via lipid nanoparticles to reprogram solid-tumor cancer cells into immune-like cells.
AI & Machine LearningBiotechDeep TechSan Carlos, US
Rustam Esanov(Co-founder & CEO)inEziz Kuliyev(Co-founder & COO)inAngela Yang(Head of Research)inAnnageldi Tayyrov(Head of AI Platform)in
Co-investorsNarya Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.